Общественная организация "Здоровье. Информированный выбор!"

С вопросами и предложениями обращайтесь по адресам:
privivkam-net@yandex.ru
Сотрудничество, обмен баннерами и размещение рекламы на форуме >>
Финансовая помощь проекту >>
                    
Сообщения без ответов | Активные темы Текущее время: Чт апр 24, 2014 6:01 pm



Ответить на тему  [ Сообщений: 8 ] 
 Лечебное голодание. 
Автор Сообщение
Сообщение Лечебное голодание.
Огромный англо-язычный ресурс с доказательными исследованиями в области диетологии и лечебного голодания:
http://antiaging-europe.com/lists/30/diseases.html
интересный контраст - заоблачные цены на проведение голодания, звездочные отели, хорошая научная база и "дохлый форум".
У нас - все наоборот: толпы энтузиастов с веселым форумом по лечебному голоданию:
http://golodanie.su/index.php
бесплатное голодание в любой деревне с удобствами на улице, самоустранение врачей, как оказалось, от вполне научного метода лечения.
Этот дисбаланс нужно устранить.
Они к нам или мы к ним? Срочно брататься!
Можно утереть не только нос всем говорунам против РДТ (лечебного голодания).


Сб май 24, 2008 4:35 am
Сообщение 
Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year.
Diabet Med. 2003 Apr;20(4):319-24
Dhindsa P, Scott AR, Donnelly R.
School of Medical & Surgical Sciences, University of Nottingham, and Jenny O'Neil Diabetes Centre, Southern Derbyshire Acute Hospitals, NHS Trust, Derby, UK.
AIMS: To evaluate the short-term and 1-year outcomes of an intensive very-low-calorie diet (VLCD) on metabolic and cardiovascular variables in obese patients with Type 2 diabetes (T2DM) and symptomatic hyperglycaemia despite combination oral anti-diabetic therapy +/- insulin, and to assess patient acceptability and the feasibility of administering VLCD treatment to this subgroup of patients in a routine practice setting. METHODS: Forty obese patients with T2DM (22 M, mean age 52 years, body mass index (BMI) 40 kg/m2, duration of T2DM 6.1 years) and symptomatic hyperglycaemia despite combination oral therapy (n = 26) or insulin + metformin (n = 14) received 8 weeks of VLCD therapy (750 kcal/day) followed by standard diet and exercise advice at 2-3-month intervals up to 1 year. Insulin was discontinued at the start of the VLCD, and anti-diabetic therapy was adjusted individually throughout the study, including (re)commencement of insulin as required. RESULTS: Immediate improvements in symptoms and early weight loss reinforced good compliance and patient satisfaction. After 8 weeks of VLCD, body weight and BMI had fallen significantly: 119 +/- 19-107 +/- 18 kg and 40.6-36.6 kg/m2, respectively, with favourable reductions in serum total cholesterol (5.9-4.9 mm), blood pressure (10/6 mmHg) and fructosamine (386 +/- 73-346 +/- 49 microm) (equates to an HbA1c reduction of approximately 1%). Sustained improvements were evident after 1 year, with minimal weight regain, e.g. mean body weight 109 +/- 18 kg and BMI 37 +/- 4 kg/m2. Glycaemic control tended to deteriorate after 1 year. CONCLUSIONS: The absence of a control group is a major limitation, but the results indicate that 8 weeks of VLCD treatment may be effective and well tolerated in symptomatic obese patients with T2DM in secondary failure, producing sustained cardiovascular and metabolic improvements after 1 year. VLCD therapy is a treatment option that deserves greater consideration in this difficult-to-treat patient population.
Very-low-calorie-diets: is there a place for them in the management of the obese diabetic?
Diabetes Metab 2000 Jun;26 Suppl 3:46-51
Monnier L; Colette C; Percheron C; Boniface H.
Service des Maladies Metaboliques, Hopital Lapeyronie, Montpellier.
It is well-recognized that standard caloric restrictions (1500 kcal/day) are usually poorly effective in achieving weight losses in overweight type 2 diabetic patients. For that reason very-low-calorie-diets (VLCDs) were developed as a mean for initiating or accelerating weight reduction. Short-term studies indicate that VLCDs result generally in weight losses that are three times greater than those obtained with standard low-calorie-diets. Fasting blood glucose values are improving in parallel to weight losses and in many patients the improvement in glycemic control is better than that expected from the magnitude of weight losses. However the results are rather disappointing after several months or years of follow-up. For example it has been demonstrated that weight regain can be observed as soon as the patient is shifted to a refeeding or maintenance dietary program at the end of the VLCD period. Long-term results on glycemic control and body weight reduction are generally similar with standard low-calorie-diets and with VLCDs, the final results depending on the magnitude of weight loss whatever the prescribed diet. At short-term the VLCDs can be helpful first for initiating weight losses and second for sensitizing the patient to the potential benefits of complying to dietary measures.
Aggressive weight reduction treatment in the management of type 2 diabetes.
Diabetes Metab 1998 Apr;24(2):116-23
Scheen AJ. Department of Medicine,
CHU Sart Tilman, Belgium.
Most patients with Type 2 diabetes are significantly overweight, and diet-induced weight loss can provide marked improvement in their glycaemic control. As conventional therapy combining diet and exercise usually has a poor long-term success rate, more aggressive weight reduction programmes have been proposed for the treatment of severely obese diabetic patients, including very-low-calorie diets, anti-obesity drugs and bariatric surgery. Very-low-calorie diets usually have a remarkable short-term effect, and energy restriction and weight reduction are positive factors for the glycaemic control of obese diabetic subjects. However, the long-term efficacy of these methods remains doubtful since weight regain is a common phenomenon. Although anti-obesity (anorectic) drugs may help patients to follow a restricted diet and lose weight, their overall efficacy on body weight and glycaemia is generally modest, and their long-term safety still questionable. Interestingly, serotoninergic anorectic agents have been shown to improve both the insulin sensitivity and glycaemic control of obese diabetic patients independently of weight loss. Bariatric surgery may be helpful in well-selected patients. The correction of weight excess after successful gastroplasty fully reverses the abnormalities of insulin secretion, clearance and action on glucose metabolism present in markedly obese non-diabetic patients, and allows interruption or reduction of insulin therapy and antidiabetic oral agents in most obese diabetic patients. In conclusion, weight loss is a major goal in treating obese patients with Type 2 diabetes, and aggressive weight reduction programmes may be used in selected patients refractory to conventional diet and drug treatment. However, long-term prospective studies are needed for more precise determination of the role of such a strategy in the overall management of obese diabetic patients.
Improved metabolic control after supplemented fasting in overweight type 2 diabetic patients.
Acta Med Scand. 1984;216(1):67-74.
Vessby B, Boberg M, Karlstrom B, Lithell H, Werner I.
Twenty obese type II diabetes patients were treated in a metabolic ward during 4 weeks with a very low calorie regimen (200 kcal/day). They were given dietary advice and reexamined 3 months after discharge. Mean body weight decreased by 10 kg during fasting, blood glucose was normalized, urinary glucose disappeared and the K-value at i.v. glucose tolerance test increased. Fasting serum insulin concentrations decreased by 54%. Serum triglycerides (TG) decreased by 65%, serum cholesterol (Chol) by 28% and high density lipoprotein (HDL) Chol by 14%. Three months later, only serum TG remained significantly decreased (-47%) while HDL Chol was significantly higher than on admission (+11%). Fasting blood glucose remained significantly lower (-25%) with a low urinary glucose excretion. Supplemented fasting appears to be a safe and useful tool in the treatment of obese type 2 diabetics. It causes, at least during a limited follow-up period, a significant improvement in glucose control and lipoprotein metabolism in spite of a concomitant reduction of the antidiabetic medication.
Maturity-onset diabetes mellitus--toward a physiological appropriate management.
Med Hypotheses. 1981 Oct;7(10):1265-85.
McCarty MF.
"Eumetabolic" therapies of diabetes are defined as those which promote and potentiate a normal physiological pattern of insulin activity--in contrast to the less subtle effects of exogenous insulin or sulfonylureas. Effective eumetabolic therapy would provide better metabolic control and reduce the risk of secondary complications, would be more convenient to administer, and would be especially appropriate for preventive use in the early stages of diabetes. Possible components of a eumetabolic therapy include: aspirin, as a potentiator of glucose-stimulated insulin secretion; GTF, to directly enhance the efficacy of insulin; weight loss, exercise, and fasting, to help reduce tissue resistance to insulin; mitochondrial "metavitamins", to optimize the oxidative disposal of excess substrate; a high-fiber, low-fat diet, which appears superior to traditional diabetic diets as a promoter of glucose tolerance. Following a prolonged fast, obese diabetics show substantial improvement in most parameters of insulin function--an effect which is to some degree independent of weight loss; long-term remission of diabetes may be possible if the benefits of therapeutic fasting are conserved by appropriate eumetabolic measures.
Insulinemia in the obese before and after fasting therapy
Journ Annu Diabetol Hotel Dieu. 1969;10:287-92.
[Article in French]
Gueris J, Segrestaa JM, Lamotte M.
EXPERIMENTAL EVIDENCE:
Dietary restriction and glucose regulation in aging rhesus monkeys: a follow-up report at 8.5 yr.
Am J Physiol Endocrinol Metab 2001 Oct;281(4):E757-65
Gresl TA, Colman RJ, Roecker EB, Havighurst TC, Huang Z, Allison DB, Bergman RN, Kemnitz JW.
Wisconsin Regional Primate Research Center, Madison 53715, USA.
In a longitudinal study of the effects of moderate (70%) dietary restriction (DR) on aging, plasma glucose and insulin concentrations were measured from semiannual, frequently sampled intravenous glucose tolerance tests (FSIGTT) in 30 adult male rhesus monkeys. FSIGTT data were analyzed with Bergman's minimal model, and analysis of covariance revealed that restricted (R) monkeys exhibited increased insulin sensitivity (S(I), P < 0.001) and plasma glucose disappearance rate (K(G), P = 0.015), and reduced fasting plasma insulin (I(b), P < 0.001) and insulin response to glucose (AIR(G), P = 0.023) compared with control (C; ad libitum-fed) monkeys. DR reduced the baseline fasting hyperinsulinemia of two R monkeys, whereas four C monkeys have maintained from baseline, or subsequently developed, fasting hyperinsulinemia; one has progressed to diabetes. Compared with only the normoinsulinemic C monkeys, R monkeys exhibited similarly improved FSIGTT and minimal-model parameters. Thus chronic DR not only has protected against the development of insulin resistance in aging rhesus monkeys, but has also improved glucoregulatory parameters compared with those of otherwise normoinsulinemic monkeys.
Intermittent feeding and fasting reduces diabetes incidence in BB rats.
Autoimmunity 1999;30(4):243-50
Pedersen CR; Hagemann I; Bock T; Buschard K.
Bartholin Instituttet, Kommunehospitalet, Copenhagen, Denmark.
Food intake may be one of several factors which influence the risk of development of insulin dependent diabetes mellitus, but the influence of the pattern of food supply has not been studied previously. The aim of the present study was to investigate the effect of intermittent feeding and fasting upon diabetes in BB rats. This study included three groups. Group 1 served as control and included 77 animals, 79% became diabetic. In groups 2 and 3, after weaning, food but not water was withdrawn from the animals: 24 h twice a week in group 2; 24 h every second day in group 3. Group 2 included 40 BB rats, 50% (p < 0.004) became diabetic. Group 3 included 44 BB rats, 52% (p < 0.01) became diabetic. No differences were seen between sexes. Degree of insulitis was not influenced by changed food supply. Regarding blood glucose, no influence was seen among diabetic animals, among non-diabetic animals changed food supply reduced blood glucose values obtained at the end of the study. Intermittent feeding and fasting tended to reduce mean age at the time of diagnosis of diabetes, significance was reached only in female animals from group 3 compared to group 1. Body weight was obtained weekly. Intermittent feeding and fasting caused a reduced weight gain in group 2 as well as in group 3 compared to control animals; however, most pronounced in group 3 and also more pronounced among males compared to females. For pre-diabetic and non-diabetic animals comparable influence on body weight was seen. The main conclusion in the study is that intermittent feeding and fasting reduced diabetes incidence.
http://antiaging-europe.com/lists/30/diseases.html


Ср май 28, 2008 5:13 am
Сообщение 
Fasting by Ron Lagerquist:
http://www.freedomyou.com/level%202/Fas ... 0Guide.htm


Ср май 28, 2008 6:50 pm
Сообщение 
Подборка материалов из научных журналов по лечению ревматических заболеваний методом лечебного голодания на разных языках.

Short-term therapeutic fasting in the treatment of chronic pain and fatigue syndromes - well-being and side effects with and without mineral supplements [Article in German].
Кратковременное лечебное голодание при лечении синдромов хронической боли и хронической усталости, побочных эффектов лекарственной терапии без применения минеральных пищевых добавок. Статья на немецком языке, резюме на английском.
CONCLUSIONS: Short-term fasting in patients with pain and stress syndromes is safe and well tolerated, concomitant mineral supplements have no additive benefit.
ВЫВОД: Кратковременное лечебное голодание пациентов с хронической болью и синдромом напряжения безопасно, хорошо переносится. Применение минеральных пищевых добавок не дает преимуществ.

Fasting followed by vegetarian diet in patients with rheumatoid arthritis: a systematic review.
Систематический обзор литературы по лечебному голоданию с последующим соблюдением вегетарианской диеты больных с ревматоидным артритом.

Effects of a low calorie vegan diet on disease activity and general conditions in patients with rheumatoid arthritis [Article in Japanese].
Эффекты низкокалорийной вегетарианской диеты на активность заболевания и общее состояние больных с ревматоидным артритом. Статья на японском языке, резюме на английском.

Changes in laboratory variables in rheumatoid arthritis patients during a trial of fasting and one-year vegetarian diet.
Динамика изменений лабораторных параметров у больных с ревматоидным артритом во время контролируемых исследований влияния лечебного голодания и соблюдения вегетарианской диеты в течение года.

Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis.
Контролируемые исследования лечебного голодания и соблюдения вегетарианской диеты при лечении ревматоидного артрита.

Резюме полностью.
Short-term therapeutic fasting in the treatment of chronic pain and fatigue syndromes--well-being and side effects with and without mineral supplements [Article in German].
Forsch Komplementarmed Klass Naturheilkd 2002 Aug;9(4):221-7.
Michalsen A, Weidenhammer W, Melchart D, Langhorst J, Saha J, Dobos G.
Abteilung fur Innere Medizin V, Naturheilkunde und Integrative Medizin, Kliniken Essen Mitte, Essen.

Fasting followed by vegetarian diet has shown to be an effective treatment for rheumatoid arthritis, moreover fasting is frequently used as an adjunctive treatment in chronic pain and stress/exhaustion syndromes. Data on well-being and the frequency of side effects during fasting are mostly retrospective. Mineral supplements are frequently used in order to compensate for fasting-induced tissue acidosis and to reduce side effects. There are only limited data that support this practice. OBJECTIVE: To study the effects of oral mineral supplements on common side effects and well-being during short-term fasting. PATIENTS AND METHODS: 209 consecutive inpatients with chronic pain/exhaustion syndromes were recruited. In a controlled non-randomised study design all patients underwent fasting (250 kcal; 3 l fluid intake/day) over 7 days, in study phase 1 without (n = 103) and in study phase 2 with (n = 106) concomitant prescription of standardised oral mineral supplements (3 x 2 to 3 x 3 Bullrich's Vital). Weight, blood pressure and urinary pH were recorded daily. Well-being and mood as well as common side effects (i.e. fatigue, hunger, heart burn, headache) were assessed with standardised self-reports. RESULTS: Baseline characteristics of the 209 patients (mean age 54.7 +/- 10.5 years; 83.3% female) were balanced. Both groups showed a fasting-induced decrease of blood pressure, a slight decrease in mood and well-being on days 3 and 4 with consecutive increase and moderate hunger, i.e. in the evening. Side effects and general tolerability of fasting as well as well-being and mood were not different between the groups. There were no serious side effects in both groups. CONCLUSIONS: Short-term fasting in inpatients with pain and stress syndromes is safe and well tolerated, concomitant mineral supplements have no additive benefit.


Fasting followed by vegetarian diet in patients with rheumatoid arthritis: a systematic review.
Scand J Rheumatol 2001;30(1):1-10.
Muller H, de Toledo FW, Resch KL.
Balneology and Rehabilitation Sciences Research Institute (FBK), Bad Elster, Germany.

Clinical experience suggests that fasting followed by vegetarian diet may help patients with rheumatoid arthritis (RA). We reviewed the available scientific evidence, because patients frequently ask for dietary advice, and exclusive pharmacological treatment of RA is often not satisfying. Fasting studies in RA were searched in MEDLINE and by checking references in relevant reports. The results of the controlled studies which reported follow-up data for at least three months after fasting were quantitatively pooled. Thirty-one reports of fasting studies in patients with RA were found. Only four controlled studies investigated the effects of fasting and subsequent diets for at least three months. The pooling of these studies showed a statistically and clinically significant beneficial long-term effect. Thus, available evidence suggests that fasting followed by vegetarian diets might be useful in the treatment of RA. More randomised long-term studies are needed to confirm this view by methodologically convincing data.


Effects of a low calorie vegan diet on disease activity and general conditions in patients with rheumatoid arthritis [Article in Japanese].
Rinsho Byori 1999 Jun;47(6):554-60.
Fujita A, Hashimoto Y, Nakahara K, Tanaka T, Okuda T, Koda M.
Clinical Research Laboratory, Sunstar Co. Ltd., Takatsuki.

There is little objective information about diet therapy for rheumatoid arthritis (RA) in Japan. We studied 14 patients with RA who stayed in the Koda hospital for 55 days. They basically took a 1200 kcal vegan diet consisting of unpolished rice gruel, juice of raw vegetables, soya bean curd and sesame seeds, and undertook a 3-5-day fast three times. During the 55-day stay, average body weight decreased by 5.1kg. Lansbury index and ESR decreased whereas CRP did not change. WBC decreased and the differential cell counts showed a decrease of neutrophils, eosinophils and monocytes without a change in lymphocytes or basophils. RBC, hemoglobin and MCV increased. LDL-C decreased, while HDL-C increased. There was no change in total protein or albumin. These data suggest that this combination of a low calorie vegan diet and fasting may contribute to improve RA with little undesirable effects on the patient's general conditions.


Changes in glycosylation of IgG during fasting in patients with rheumatoid arthritis.
Br J Rheumatol 1996 Feb;35(2):117-9.
Kjeldsen-Kragh J, Sumar N, Bodman-Smith K, Brostoff J.
Institute of Immunology and Rheumatology, The National Hospital, Olso, Norway.

Patients with rheumatoid arthritis (RA) have a higher proportion of agalactosyl IgG than healthy individuals. Glycosylation status was examined in 26 RA patients who fasted for 7-10 days and afterwards followed a vegetarian diet for 3.5 months. The decrease in the proportion of agalactosyl IgG correlated significantly with the clinical improvement after the fasting period, but not after the vegetarian diet period. Although the glycosylation status of IgG may have played a role in the improvement of disease during the fasting period, it did not seem to be associated with, and therefore responsible for, the clinical improvement observed after the vegetarian diet.

Changes in laboratory variables in rheumatoid arthritis patients during a trial of fasting and one-year vegetarian diet.
Scand J Rheumatol. 1995;24(2):85-93.
Kjeldsen-Kragh J, Mellbye OJ, Haugen M, Mollnes TE, Hammer HB, Sioud M, Forre O.
Institute of Immunology and Rheumatology, National Hospital, Oslo, Norway.

We have previously reported that significant improvement may be obtained in rheumatoid arthritis patients by fasting followed by a vegetarian diet for one year. The present study was carried out to examine to what extent biochemical and immunological variables changed during the clinical trial of fasting and vegetarian diet. For the patients who were randomised to the vegetarian diet there was a significant decrease in platelet count, leukocyte count, calprotectin, total IgG, IgM rheumatoid factor (RF), C3-activation products, and the complement components C3 and C4 after one month of treatment. None of the measured parameters changed significantly during this period in the group of omnivores. The course of 14 of 15 measured variables favored the vegetarians compared with the omnivores, but the difference was only significant for leukocyte count, IgM RF, and the complement components C3 and C4. Most of the laboratory variables declined considerably in the vegetarians who improved according to clinical variables, indicating a substantial reduction in inflammatory activity. The leukocyte count, however, decreased in the vegetarians irrespective of the clinical results. Thus, the decline in leukocyte count may be attributed to vegetarian diet per se and not to the reduction in disease activity. The results of the present study are in accordance with the findings from the clinical trial, namely that dietary treatment can reduce the disease activity in some patients with rheumatoid arthritis.


Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis.
Lancet. 1991 Oct 12;338(8772):899-902.
Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Laerum E, Eek M, Mowinkel P, Hovi K, Forre O.
Department of General Practice, University of Oslo, Norway.

Fasting is an effective treatment for rheumatoid arthritis, but most patients relapse on reintroduction of food. The effect of fasting followed by one year of a vegetarian diet was assessed in a randomised, single-blind controlled trial. 27 patients were allocated to a four-week stay at a health farm. After an initial 7-10 day subtotal fast, they were put on an individually adjusted gluten-free vegan diet for 3.5 months. The food was then gradually changed to a lactovegetarian diet for the remainder of the study. A control group of 26 patients stayed for four weeks at a convalescent home, but ate an ordinary diet throughout the whole study period. After four weeks at the health farm the diet group showed a significant improvement in number of tender joints, Ritchie's articular index, number of swollen joints, pain score, duration of morning stiffness, grip strength, erythrocyte sedimentation rate, C-reactive protein, white blood cell count, and a health assessment questionnaire score. In the control group, only pain score improved score. In the control group, only pain score improved significantly. The benefits in the diet group were still present after one year, and evaluation of the whole course showed significant advantages for the diet group in all measured indices. This dietary regimen seems to be a useful supplement to conventional medical treatment of rheumatoid arthritis.

Rheumatoid arthritis (RA) or fibromyalgia (FM)
BMC Complement Altern Med. 2005 Dec 22;5:22
Mediterranean diet or extended fasting's influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid arthritis and fibromyalgia: an observational study.
Michalsen A, Riegert M, Ludtke R, Backer M, Langhorst J, Schwickert M, Dobos GJ.
Kliniken Essen-Mitte, Department of Internal and Integrative Medicine, University Duisburg-Essen, am Deimelsberg 34a, 45276 Essen, Germany. .

BACKGROUND: Alterations in the intestinal bacterial flora are believed to be contributing factors to many chronic inflammatory and degenerative diseases including rheumatic diseases. While microbiological fecal culture analysis is now increasingly used, little is known about the relationship of changes in intestinal flora, dietary patterns and clinical outcome in specific diseases. To clarify the role of microbiological culture analysis we aimed to evaluate whether in patients with rheumatoid arthritis (RA) or fibromyalgia (FM) a Mediterranean diet or an 8-day fasting period are associated with changes in fecal flora and whether changes in fecal flora are associated with clinical outcome. METHODS: During a two-months-period 51 consecutive patients from an Integrative Medicine hospital department with an established diagnosis of RA (n = 16) or FM (n = 35) were included in the study. According to predefined clinical criteria and the subjects' choice the patients received a mostly vegetarian Mediterranean diet (n = 21; mean age 50.9 +/-13.3 y) or participated in an intermittent modified 8-day fasting therapy (n = 30; mean age 53.7 +/- 9.4 y). Quantitative aerob and anaerob bacterial flora, stool pH and concentrations of secretory immunoglobulin A (sIgA) were analysed from stool samples at the beginning, at the end of the 2-week hospital stay and at a 3-months follow-up. Clinical outcome was assessed with the DAS 28 for RA patients and with a disease severity rating scale in FM patients. RESULTS: We found no significant changes in the fecal bacterial counts following the two dietary interventions within and between groups, nor were significant differences found in the analysis of sIgA and stool ph. Clinical improvement at the end of the hospital stay tended to be greater in fasting vs. non-fasting patients with RA (p = 0.09). Clinical outcome was not related to alterations in the intestinal flora. CONCLUSION: Neither Mediterranean diet nor fasting treatments affect the microbiologically assessed intestinal flora and sIgA levels in patients with RA and FM. The impact of dietary interventions on the human intestinal flora and the role of the fecal flora in rheumatic diseases have to be clarified with newer molecular analysis techniques. The potential benefit of fasting treatment in RA and FM should be further tested in randomised trials.
http://antiaging-europe.com/lists/31/diseases.html


Вт июн 10, 2008 7:10 am
Сообщение 
С особой гордостью за русскую медицину и нашу медицинскую литературу делаю ссылки на лечение бронхиальной астмы методом лечебного голодания.
Все иностранные авторы ссылаются на работы наших врачей, фамилии которых известны.
According to Dr. Fuhrman’s observations ( Dr. Joel Fuhrman M.D."Fasting and Eating for Health", St. Martin’s Griffin, New York, 1995) the more severe the asthma and the greater the dependency on medication, the longer it takes to archive a recovery when we apply natural methods. He have found that a long fast, or sometimes two fasts with impeccable dietary habits in between, is usually essential for the resolution when the patient has been dependent on multiple medications for many years. The beneficial effects of fasting in asthmatics have been well documented in the Russian medical literature. Their clinical trials illustrated that more than 75 percent of patients had greatly improved conditions or never had symptoms of asthma again after fasting.
В книге «Голодание и пища для здоровья», Joel Fuhrman, НЬЮ-ЙОРК, 1995, пишет, что эффективность лечебного голодания при бронхиальной астме хорошо иллюстрируется в Русской медицинской литературе. Клинические испытания показали, что более, чем в 75 процентах случаев происходит существенное улучшение состояния или полное исчезновение бронхиальной астмы после лечебного голодания.Ссылки на русские! литературные источники на английском языке, думаю, в переводах не нуждаются! Наоборот, нужно было бы найти эти статьи на русском.
Effectiveness of short courses of fasting in pre-asthma and asthma patients
[Article in Ukrainian].
Lik Sprava 2002 Apr-Jun;(3-4):79-81.
Asthma Klin Med (Mosk) 1991 Apr;69(4):54-6.
Dzhugostran VIa; Niamtsu ET; Zlepka VD; Marchenko IuG.
Ter Arkh. 1991;63(3):100-3. [Article in Russian].
Kokosov AN, Osinin SG, Faustova ME.
Use of controlled therapeutic fasting in bronchial asthma.
Adravookhr Belorus 1979; 0 (9): 55-58.
Gorbachev VV, Sytyi VP, Sizova EP, Vasnev VI, Boyarintseva AV.
Нашел ссылку на книгу "Fasting and Eating for Health":
http://www.amazon.com/Fasting-Eating.../dp/0312130716
http://www.alibris.com/search/books/qwo ... 0A%20Medic al%20Doctor's%20Program%20for%20Conquering%20Disea se
Fasting-And Eating-For Health: A Medical Doctor's Program for Conquering Disease. by Joel Fuhrman, John A McDougall
About this title: This is not another diet book but a systematic approach to therapeutic fasting for health and healing. Dr. Furhman has created a career out of helping people learn how to fast and to benefit from the effects of a healthy, life-enhancing diet. Common maladies such as obesity, asthma, rheumatoid arthritis, and psoriasis, to name just a few, are all positively affected by short, controlled fasts. Dr. Furhman is clear that no fast should last longer than three days without a physician's supervision and gives sound nutritional advice for beginning and breaking a fast.
Голодание и пища для здоровья. Это - не новая кулинарная книга, а методическое пособие по лечебному голоданию для профилактики и лечения. Такие заболевания, как ожирение, бронхиальная астма, ревматоидный артрит и псориаз быстро и эффективно контролируются голоданием.
Эта книга или нет, но очень много восторженных отзывов.
Есть ли на русском языке? Там еще много хороших книг. Имел ли кто опыт заказа книг из-за рубежа, какие формы оплаты и как они доходят? Можно предложить зарубежным товарищам, у кого есть эта книга частями выкладывать и переводить, если там есть что-нибудь кроме цитат работ наших исследователей!
http://antiaging-europe.com/lists/95/diseases.html


Ср июн 11, 2008 5:47 am
Сообщение 
A case of obesity, diabetes and hypertension treated with very low calorie diet (VLCD) followed by successful pregnancy with intrauterine insemination (IUI).
Endocr J 2000 Dec;47(6):787-91.
Katsuki A, Sumida Y, Ito K, Murashima S, Gabazza EC, Furuta M, Yano Y, Sugiyama T, Toyoda N, Adachi Y.
Third Department of Internal Medicine, Mie University School of Medicine, Tsu, Japan.
The patient was a 32-year-old obese woman with a history of type 2 diabetes and hypertension for 6 years. Although she was treated with antihypertensive agents and intensive insulin therapy, her hyperglycemia was difficult to control. She wanted to have a baby but pregnancy was not recommended because her diabetes was under poor control and the use of antihypertensive medication. To achieve good control of obesity, diabetes and hypertension, she was admitted to our clinical department for weight reduction using very low calorie diet (VLCD). During VLCD she had a 19.8 kg reduction in body weight and her blood glucose and blood pressure were in good control without the use of drugs. Five months later, she became pregnant after the fourth trial of intrauterine insemination (IUI) and gave birth to a female baby under insulin therapy. This is the first report that showed the usefulness of VLCD for prepregnant control of glucose metabolism and blood pressure in an obese hypertensive patient with type 2 diabetes mellitus.

Rejuvenating effects of 10-week underfeeding period on estrous cycles in young and old rats.
Neurobiol Aging 1987 May-Jun;8(3):225-32.
Quigley K; Goya R; Meites J.
The effects of providing 50% of normal feed intake for 10 weeks followed by 16 weeks of ad lib feeding on estrous cycles and mammary tumor incidence were studied in female rats initially 4 months and 15-16 months old. Initially all young rats exhibited regular or irregular estrous cycles and only about 41% of the older rats cycled regularly or irregularly; the remainder of the older rats did not cycle. During underfeeding, both the young and older rats lost body weight and ceased to cycle. After refeeding 100% of both young and old rats resumed cycling, the young rats for a much longer period than the old rats, and more of both groups continued to cycle than their ad lib-fed controls. Upon refeeding, the young and old rats reached the body weights of the ad lib-fed controls in about 3 weeks. Mammary tumors were initially present only in old rats and regressed during underfeeding; they rapidly reached control size upon refeeding. Plasma PRL levels declined during underfeeding but rebounded to higher than control values upon refeeding in both young and old rats. In young but not in old rats, plasma LH levels fell during underfeeding but returned to control values upon refeeding. These results demonstrate that a relatively short period of underfeeding, followed by refeeding, can delay the decline in reproductive cycles in young rats and reinitiate estrous cycles in older rats. These effects appear to be mediated via the neuroendocrine system.
http://antiaging-europe.com/lists/65/diseases.html


Сб июн 21, 2008 5:27 pm
Сообщение 
Что такое лечебное голодание или, как его еще называют, разгрузочно-диетическая терапия, что происходит в организме при голодании и почему благодаря этому методу можно избавиться практически от любого заболевания внутренних органов, как правильно выходить из голодания? Обо всем этом рассказывает доктор медицинских наук, профессор, главный научный сотрудник НИИ пульмонологии Санкт-Петербургского научного университета им. И. П. Павлова Алексей Кокосов.
Голоданию - зеленая улица.
Лечебным голоданием я занимаюсь уже около 30 лет. С того самого времени, когда московский профессор-психиатр Юрий Сергеевич Николаев установил, что дозированное лечебное голодание, позже это стало называться разгрузочно-диетическая терапия, помогает не только при психических заболеваниях, но и при заболеваниях ряда внутренних органов. В том числе при бронхиальной астме. Тогда, 30 лет назад, бронхиальная астма входила в ранг социально значимых болезней. А опыт Николаева показывал, что в отдельных случаях голодание помогает при бронхиальной астме. Минздрав дал задание нашему институту разобраться, так ли это, и, если действительно помогает, сделать методические рекомендации и внедрить в практику. Поручили эту работу мне. Я познакомился с Николаевым, и мы, засучив рукава, принялись за работу. Пошли классическим путем: исследовали больных на определенных этапах голодания и делали клинико-лабораторные срезы. В результате мы вникли в суть того, что происходит в организме при голодании и почему этот метод помогает. Я направил в Министерство здравоохранения положительные рекомендации, после чего методу лечебного голодания была дана в Союзе зеленая улица.
http://health.rambler.ru/articles/10659/


Пт июл 04, 2008 1:06 pm
Модератор

Зарегистрирован: Пн фев 09, 2009 11:11 pm
Сообщений: 642
Откуда: Иркутск
Сообщение 
На Гаити спасатели обнаружили живым 28-летнего мужчину.
Под руинами он пролежал 27дней. Специалисты называют произошедшее настоящим чудом. В момент землетрясения мужчина был на рынке. Именно там, под обломками бетона его нашли родственники. Сейчас он в полевом госпитале. Сообщается, что мужчина очень слаб. За его жизнь борются врачи.
«В это трудно поверить, но как оказалось, нет ничего невозможного. Мужчину к нам принесли его родственники. У него крайняя степень обезвоживания. Мы поместили пациента в отделение интенсивной терапии и вводим ему лекарства внутривенно. Думаю, он поправится», — говорит Дашьянта Джаявера, врач полевого госпиталя университета Майами.
Мощнейшее землетрясение на Гаити произошло 12 января нынешнего года. По последним данным, погибли 212 тысяч человек, и число жертв увеличивается с каждым днем. Их тела находят под завалами. Около трех миллионов гаитян пострадали, передает телеканал «Россия 24».
http://news.mail.ru/incident/3355854/


Чт фев 11, 2010 7:49 pm
Профиль WWW
Показать сообщения за:  Сортировать по:  
Ответить на тему   [ Сообщений: 8 ] 

Кто сейчас на форуме

Сейчас этот форум просматривают: нет зарегистрированных пользователей и гости: 0


Вы не можете начинать темы
Вы не можете отвечать на сообщения
Вы не можете редактировать свои сообщения
Вы не можете удалять свои сообщения
Вы не можете добавлять вложения

Найти:
Перейти:  

Техническая поддержка CYGNUS HOSTING

Мы в Твиттере
Powered by phpBB © 2000, 2002, 2005, 2007 phpBB Group.
Designed by STSoftware for PTF.
Русская поддержка phpBB